Cargando…

655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance

BACKGROUND: Antibiotic-resistant bacteria are spread through selective pressure from the use of broad-spectrum empirical therapies, mobile genetic elements that pass resistance genes between species, and the inability to rapidly and appropriately respond to their presence. Resistance gene identifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Jessica L, Manning, Brendan, Shivers, Robert, Gamero, Daniel, Giese, Heidi, Phung, Nu, Chang, Benjamin, Lapp, Heather, Paggi, Riccardo, Posteraro, Brunella, Sanguinetti, Maurizio, De Angelis, Giulia, Mencacci, Antonella, Lowery, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810963/
http://dx.doi.org/10.1093/ofid/ofz360.723
_version_ 1783462363214643200
author Snyder, Jessica L
Manning, Brendan
Shivers, Robert
Gamero, Daniel
Giese, Heidi
Phung, Nu
Chang, Benjamin
Lapp, Heather
Paggi, Riccardo
Posteraro, Brunella
Sanguinetti, Maurizio
De Angelis, Giulia
Mencacci, Antonella
Lowery, Thomas J
author_facet Snyder, Jessica L
Manning, Brendan
Shivers, Robert
Gamero, Daniel
Giese, Heidi
Phung, Nu
Chang, Benjamin
Lapp, Heather
Paggi, Riccardo
Posteraro, Brunella
Sanguinetti, Maurizio
De Angelis, Giulia
Mencacci, Antonella
Lowery, Thomas J
author_sort Snyder, Jessica L
collection PubMed
description BACKGROUND: Antibiotic-resistant bacteria are spread through selective pressure from the use of broad-spectrum empirical therapies, mobile genetic elements that pass resistance genes between species, and the inability to rapidly and appropriately respond to their presence. Resistance gene identification is often performed with post culture molecular diagnostic tests. The T2Resistance Panel, which detects methicillin resistance genes mecA/C; vancomycin resistance genes vanA/B; carbapenemases bla(KPC), bla(OXA-48),bla(NDM), bla(VIM), and bla(IMP); AmpC β-lactamases bla(CMY) and bla(DHA); and extended-spectrum β-lactamases bla(CTX-M) directly from patient blood samples, is based on T2 magnetic resonance (T2MR), an FDA-cleared technology with demonstrated high sensitivity and specificity for culture-independent bacterial and fungal species identification. Here we report the clinical performance of T2MR detection of resistance genes directly from patient blood samples. METHODS: Patients with a clinical diagnosis of sepsis and an order for blood culture (BC) were enrolled in the study at two sites. BCs were managed using standard procedures and MALDI-TOF for species identification. Resistance testing with the T2MR assay was performed on a direct patient draw and compared with diagnostic test results from concurrent BC specimen and BC specimen taken at other points in time. The potential impact on therapy was evaluated through patient chart review. RESULTS: T2MR detected the same resistance genes as detected by post culture diagnostics in 100% of samples from concurrent blood draws. Discordant results occurred when T2MR was taken ≥48 hours after BC for patients on antimicrobial therapy. The average time to positive result was 5.9 hours with T2MR vs. 30.6 hours with post-culture molecular testing. CONCLUSION: The T2Resistance Panel detected antibiotic resistance genes in clinical samples and displayed agreement with post culture genetic testing. T2MR results were achieved faster than culture-dependent diagnostic testing results and may allow for an earlier change from empiric to directed therapy. The use of culture-independent diagnostics like T2MR could enable a quicker response to antibiotic-resistant organisms for individual patients and developing outbreaks. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810963
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68109632019-10-28 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance Snyder, Jessica L Manning, Brendan Shivers, Robert Gamero, Daniel Giese, Heidi Phung, Nu Chang, Benjamin Lapp, Heather Paggi, Riccardo Posteraro, Brunella Sanguinetti, Maurizio De Angelis, Giulia Mencacci, Antonella Lowery, Thomas J Open Forum Infect Dis Abstracts BACKGROUND: Antibiotic-resistant bacteria are spread through selective pressure from the use of broad-spectrum empirical therapies, mobile genetic elements that pass resistance genes between species, and the inability to rapidly and appropriately respond to their presence. Resistance gene identification is often performed with post culture molecular diagnostic tests. The T2Resistance Panel, which detects methicillin resistance genes mecA/C; vancomycin resistance genes vanA/B; carbapenemases bla(KPC), bla(OXA-48),bla(NDM), bla(VIM), and bla(IMP); AmpC β-lactamases bla(CMY) and bla(DHA); and extended-spectrum β-lactamases bla(CTX-M) directly from patient blood samples, is based on T2 magnetic resonance (T2MR), an FDA-cleared technology with demonstrated high sensitivity and specificity for culture-independent bacterial and fungal species identification. Here we report the clinical performance of T2MR detection of resistance genes directly from patient blood samples. METHODS: Patients with a clinical diagnosis of sepsis and an order for blood culture (BC) were enrolled in the study at two sites. BCs were managed using standard procedures and MALDI-TOF for species identification. Resistance testing with the T2MR assay was performed on a direct patient draw and compared with diagnostic test results from concurrent BC specimen and BC specimen taken at other points in time. The potential impact on therapy was evaluated through patient chart review. RESULTS: T2MR detected the same resistance genes as detected by post culture diagnostics in 100% of samples from concurrent blood draws. Discordant results occurred when T2MR was taken ≥48 hours after BC for patients on antimicrobial therapy. The average time to positive result was 5.9 hours with T2MR vs. 30.6 hours with post-culture molecular testing. CONCLUSION: The T2Resistance Panel detected antibiotic resistance genes in clinical samples and displayed agreement with post culture genetic testing. T2MR results were achieved faster than culture-dependent diagnostic testing results and may allow for an earlier change from empiric to directed therapy. The use of culture-independent diagnostics like T2MR could enable a quicker response to antibiotic-resistant organisms for individual patients and developing outbreaks. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810963/ http://dx.doi.org/10.1093/ofid/ofz360.723 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Snyder, Jessica L
Manning, Brendan
Shivers, Robert
Gamero, Daniel
Giese, Heidi
Phung, Nu
Chang, Benjamin
Lapp, Heather
Paggi, Riccardo
Posteraro, Brunella
Sanguinetti, Maurizio
De Angelis, Giulia
Mencacci, Antonella
Lowery, Thomas J
655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title_full 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title_fullStr 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title_full_unstemmed 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title_short 655. Detection of Antibiotic Resistance Genes in Clinical Samples using T2 Magnetic Resonance
title_sort 655. detection of antibiotic resistance genes in clinical samples using t2 magnetic resonance
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810963/
http://dx.doi.org/10.1093/ofid/ofz360.723
work_keys_str_mv AT snyderjessical 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT manningbrendan 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT shiversrobert 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT gamerodaniel 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT gieseheidi 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT phungnu 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT changbenjamin 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT lappheather 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT paggiriccardo 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT posterarobrunella 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT sanguinettimaurizio 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT deangelisgiulia 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT mencacciantonella 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance
AT lowerythomasj 655detectionofantibioticresistancegenesinclinicalsamplesusingt2magneticresonance